Cite
HARVARD Citation
Claudiani, S. et al. (2022). Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study. Leukemia & lymphoma. 63 (6), pp. 1504-1507. [Online].